A Reversible SRC-relayed COX2 Inflammatory Program Drives Resistance to BRAF and EGFR Inhibition in BRAFV600E Colorectal Tumors.
Nature Cancer(2023)
Key words
Cancer,Cancer therapeutic resistance,Cancer therapy,Colon cancer,Proteomics,Life Sciences,general
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined